**Core Concept:** D-xylose absorption test is a diagnostic tool used to evaluate small bowel integrity and function. It involves measuring the amount of D-xylose excreted in the urine after oral administration of a known dose. Steatorrhea is a condition characterized by excessive fat in stool, indicating malabsorption.

**Why the Correct Answer is Right:** In this scenario, the patient presents with long-standing steatorrhea, which is a clinical sign of malabsorption. When D-xylose is administered orally, it should be efficiently absorbed in the small intestine and excreted in urine. In the given case, the urine D-xylose excretion is less than 4.5 g after a 25 g D-xylose load, indicating impaired small bowel function. Among the given options, celiac disease (CD) is the most plausible diagnosis because of its association with malabsorption syndromes and small bowel damage.

**Why Each Wrong Option is Incorrect:**

A. Pancreatitis: This condition primarily affects the pancreas and does not typically lead to malabsorption or steatorrhea.

B. Blind loop syndrome: This condition results from a shortened or duplicated small bowel, leading to malabsorption. However, the correct answer (CD) is also a malabsorption syndrome, making this option less likely.

D. Hereditary diffuse gastric cancer (HDGC): This is a rare genetic disorder affecting gastric epithelium, not related to small bowel dysfunction or steatorrhea.

**Clinical Pearl:** D-xylose absorption test is a quick and non-invasive procedure for diagnosing malabsorption syndromes, including CD. However, it is essential to consider other causes of malabsorption and consult the patient's clinical context to arrive at the correct diagnosis.

**Correct Answer:** Celiac disease (CD) - This condition is an autoimmune disorder causing damage to the small bowel villi, leading to malabsorption and steatorrhea. In this case, impaired D-xylose absorption supports the diagnosis of CD.